Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)
Samo za registrovane korisnike
2014
Autori
Lefaucheur, Jean-PascalAndre-Obadia, Nathalie
Antal, Andrea
Ayache, Samar S.
Baeken, Chris
Benninger, David H.
Cantello, Roberto M.
Cincotta, Massimo
de Carvalho, Mamede
De Ridder, Dirk
Devanne, Herve
Di Lazzaro, Vincenzo
Filipović, Saša
Hummel, Friedhelm C.
Jaaskelainen, Satu K.
Kimiskidis, Vasilios K.
Koch, Giacomo
Langguth, Berthold
Nyffeler, Thomas
Oliviero, Antonio
Padberg, Frank
Poulet, Emmanuel
Rossi, Simone
Rossini, Paolo Maria
Rothwell, John C.
Schonfeldt-Lecuona, Carlos
Siebner, Hartwig R.
Slotema, Christina W.
Stagg, Charlotte J.
Valls-Sole, Josep
Ziemann, Ulf
Paulus, Walter
Garcia-Larrea, Luis
Članak u časopisu (Objavljena verzija)
Metapodaci
Prikaz svih podataka o dokumentuApstrakt
A group of European experts was commissioned to establish guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until March 2014, regarding pain, movement disorders, stroke, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, consciousness disorders, tinnitus, depression, anxiety disorders, obsessive-compulsive disorder, schizophrenia, craving/addiction, and conversion. Despite unavoidable inhomogeneities, there is a sufficient body of evidence to accept with level A (definite efficacy) the analgesic effect of high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the pain and the antidepressant effect of HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC). A Level B recommendation (probable efficacy) is proposed for the antidepressant effect of low-frequency (LF) rTMS of the right DLPFC, HF-rTMS of the left DLPFC for the negative symptoms of schizophrenia, and LF-rTMS of contralesional M1... in chronic motor stroke. The effects of rTMS in a number of indications reach level C (possible efficacy), including LF-rTMS of the left temporoparietal cortex in tinnitus and auditory hallucinations. It remains to determine how to optimize rTMS protocols and techniques to give them relevance in routine clinical practice. In addition, professionals carrying out rTMS protocols should undergo rigorous training to ensure the quality of the technical realization, guarantee the proper care of patients, and maximize the chances of success. Under these conditions, the therapeutic use of rTMS should be able to develop in the coming years.
Ključne reči:
Cortex / Indication / Neurological disease / Neuromodulation / Noninvasive brain stimulation / Psychiatric disease / TMS / TreatmentIzvor:
Clinical Neurophysiology, 2014, 125, 11, 2150-2206Izdavač:
- Elsevier Ireland Ltd, Clare
Finansiranje / projekti:
- EBNeuro S.p.A, Florence, Italy
- Neinvazivna modulacija kortikalne ekscitabilnosti i plasticiteta - Razvoj metoda neinvazivne neuromodulacije centralnog nervnog sistema u ispitivanja fizioloških mehanizama, dijagnostici i terapiji (RS-MESTD-Basic Research (BR or ON)-175012)
- Fundacio Marato TV3 [PI110930]
- Lundbeck FoundationLundbeckfonden [R59-2010-5399] Funding Source: researchfish
DOI: 10.1016/j.clinph.2014.05.021
ISSN: 1388-2457
PubMed: 25034472
WoS: 000345519600005
Scopus: 2-s2.0-84927691583
Institucija/grupa
Institut za medicinska istraživanjaTY - JOUR AU - Lefaucheur, Jean-Pascal AU - Andre-Obadia, Nathalie AU - Antal, Andrea AU - Ayache, Samar S. AU - Baeken, Chris AU - Benninger, David H. AU - Cantello, Roberto M. AU - Cincotta, Massimo AU - de Carvalho, Mamede AU - De Ridder, Dirk AU - Devanne, Herve AU - Di Lazzaro, Vincenzo AU - Filipović, Saša AU - Hummel, Friedhelm C. AU - Jaaskelainen, Satu K. AU - Kimiskidis, Vasilios K. AU - Koch, Giacomo AU - Langguth, Berthold AU - Nyffeler, Thomas AU - Oliviero, Antonio AU - Padberg, Frank AU - Poulet, Emmanuel AU - Rossi, Simone AU - Rossini, Paolo Maria AU - Rothwell, John C. AU - Schonfeldt-Lecuona, Carlos AU - Siebner, Hartwig R. AU - Slotema, Christina W. AU - Stagg, Charlotte J. AU - Valls-Sole, Josep AU - Ziemann, Ulf AU - Paulus, Walter AU - Garcia-Larrea, Luis PY - 2014 UR - http://rimi.imi.bg.ac.rs/handle/123456789/555 AB - A group of European experts was commissioned to establish guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until March 2014, regarding pain, movement disorders, stroke, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, consciousness disorders, tinnitus, depression, anxiety disorders, obsessive-compulsive disorder, schizophrenia, craving/addiction, and conversion. Despite unavoidable inhomogeneities, there is a sufficient body of evidence to accept with level A (definite efficacy) the analgesic effect of high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the pain and the antidepressant effect of HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC). A Level B recommendation (probable efficacy) is proposed for the antidepressant effect of low-frequency (LF) rTMS of the right DLPFC, HF-rTMS of the left DLPFC for the negative symptoms of schizophrenia, and LF-rTMS of contralesional M1 in chronic motor stroke. The effects of rTMS in a number of indications reach level C (possible efficacy), including LF-rTMS of the left temporoparietal cortex in tinnitus and auditory hallucinations. It remains to determine how to optimize rTMS protocols and techniques to give them relevance in routine clinical practice. In addition, professionals carrying out rTMS protocols should undergo rigorous training to ensure the quality of the technical realization, guarantee the proper care of patients, and maximize the chances of success. Under these conditions, the therapeutic use of rTMS should be able to develop in the coming years. PB - Elsevier Ireland Ltd, Clare T2 - Clinical Neurophysiology T1 - Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) EP - 2206 IS - 11 SP - 2150 VL - 125 DO - 10.1016/j.clinph.2014.05.021 ER -
@article{ author = "Lefaucheur, Jean-Pascal and Andre-Obadia, Nathalie and Antal, Andrea and Ayache, Samar S. and Baeken, Chris and Benninger, David H. and Cantello, Roberto M. and Cincotta, Massimo and de Carvalho, Mamede and De Ridder, Dirk and Devanne, Herve and Di Lazzaro, Vincenzo and Filipović, Saša and Hummel, Friedhelm C. and Jaaskelainen, Satu K. and Kimiskidis, Vasilios K. and Koch, Giacomo and Langguth, Berthold and Nyffeler, Thomas and Oliviero, Antonio and Padberg, Frank and Poulet, Emmanuel and Rossi, Simone and Rossini, Paolo Maria and Rothwell, John C. and Schonfeldt-Lecuona, Carlos and Siebner, Hartwig R. and Slotema, Christina W. and Stagg, Charlotte J. and Valls-Sole, Josep and Ziemann, Ulf and Paulus, Walter and Garcia-Larrea, Luis", year = "2014", abstract = "A group of European experts was commissioned to establish guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until March 2014, regarding pain, movement disorders, stroke, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, consciousness disorders, tinnitus, depression, anxiety disorders, obsessive-compulsive disorder, schizophrenia, craving/addiction, and conversion. Despite unavoidable inhomogeneities, there is a sufficient body of evidence to accept with level A (definite efficacy) the analgesic effect of high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the pain and the antidepressant effect of HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC). A Level B recommendation (probable efficacy) is proposed for the antidepressant effect of low-frequency (LF) rTMS of the right DLPFC, HF-rTMS of the left DLPFC for the negative symptoms of schizophrenia, and LF-rTMS of contralesional M1 in chronic motor stroke. The effects of rTMS in a number of indications reach level C (possible efficacy), including LF-rTMS of the left temporoparietal cortex in tinnitus and auditory hallucinations. It remains to determine how to optimize rTMS protocols and techniques to give them relevance in routine clinical practice. In addition, professionals carrying out rTMS protocols should undergo rigorous training to ensure the quality of the technical realization, guarantee the proper care of patients, and maximize the chances of success. Under these conditions, the therapeutic use of rTMS should be able to develop in the coming years.", publisher = "Elsevier Ireland Ltd, Clare", journal = "Clinical Neurophysiology", title = "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)", pages = "2206-2150", number = "11", volume = "125", doi = "10.1016/j.clinph.2014.05.021" }
Lefaucheur, J., Andre-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., Devanne, H., Di Lazzaro, V., Filipović, S., Hummel, F. C., Jaaskelainen, S. K., Kimiskidis, V. K., Koch, G., Langguth, B., Nyffeler, T., Oliviero, A., Padberg, F., Poulet, E., Rossi, S., Rossini, P. M., Rothwell, J. C., Schonfeldt-Lecuona, C., Siebner, H. R., Slotema, C. W., Stagg, C. J., Valls-Sole, J., Ziemann, U., Paulus, W.,& Garcia-Larrea, L.. (2014). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). in Clinical Neurophysiology Elsevier Ireland Ltd, Clare., 125(11), 2150-2206. https://doi.org/10.1016/j.clinph.2014.05.021
Lefaucheur J, Andre-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipović S, Hummel FC, Jaaskelainen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schonfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). in Clinical Neurophysiology. 2014;125(11):2150-2206. doi:10.1016/j.clinph.2014.05.021 .
Lefaucheur, Jean-Pascal, Andre-Obadia, Nathalie, Antal, Andrea, Ayache, Samar S., Baeken, Chris, Benninger, David H., Cantello, Roberto M., Cincotta, Massimo, de Carvalho, Mamede, De Ridder, Dirk, Devanne, Herve, Di Lazzaro, Vincenzo, Filipović, Saša, Hummel, Friedhelm C., Jaaskelainen, Satu K., Kimiskidis, Vasilios K., Koch, Giacomo, Langguth, Berthold, Nyffeler, Thomas, Oliviero, Antonio, Padberg, Frank, Poulet, Emmanuel, Rossi, Simone, Rossini, Paolo Maria, Rothwell, John C., Schonfeldt-Lecuona, Carlos, Siebner, Hartwig R., Slotema, Christina W., Stagg, Charlotte J., Valls-Sole, Josep, Ziemann, Ulf, Paulus, Walter, Garcia-Larrea, Luis, "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)" in Clinical Neurophysiology, 125, no. 11 (2014):2150-2206, https://doi.org/10.1016/j.clinph.2014.05.021 . .